Our review found that NF2-mutated tumors defined by this Hippo signaling pathway-mediated stem cell regulation include meningiomas, schwannomas, mesotheliomas, breast cancers, hepatocellular carcinomas, renal cell carcinomas, thyroid cancers, and melanomas. The gene discussed is NF2; the disease is renal cell carcinoma.